Viking Therapeutics, Inc. (VKTX) insider trading.
In Q3 2026, insiders at Viking Therapeutics, Inc. reported 7 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $6.3M.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 3
- Net shares, P minus S
- -187,951
- Insiders
- 4
- Last filed
- 2026-08-07
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Mancini Marianna | Officer · Chief Operating Officer | 2 | 0 | 1 |
| Zante Greg | Officer · Chief Financial Officer | 2 | 0 | 1 |
| Lian Brian | Director, Officer · President & CEO | 2 | 0 | 1 |
| Kelly-Gemmell Dorothy Elizabeth | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-01 | Kelly-Gemmell Dorothy Elizabeth | A (A) | 6,333 | $0 | 6,333 | Form 4 |
| 2026-07-29 | Mancini Marianna | S (D) | 18,217 | $33.47 | 422,760 | Form 4 |
| 2026-07-29 | Zante Greg | S (D) | 21,217 | $33.47 | 212,204 | Form 4 |
| 2026-07-29 | Lian Brian | S (D) | 148,517 | $33.32 | 2,572,441 | Form 4 |
| 2026-07-28 | Mancini Marianna | A (A) | 31,667 | $0 | 440,977 | Form 4 |
| 2026-07-28 | Zante Greg | A (A) | 31,667 | $0 | 233,421 | Form 4 |
| 2026-07-28 | Lian Brian | A (A) | 221,667 | $0 | 2,720,958 | Form 4 |
Transaction codes in this quarter
Get VKTX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1607678&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · VKTX company page · Viking Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Viking Therapeutics, Inc. (VKTX)?
In Q3 2026, insiders at Viking Therapeutics, Inc. reported 7 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 3 sales worth $6.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Viking Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/vktx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.